Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230020/S006

Altius Direct Electrical Nerve Stimulation System

Neuros Medical, Inc. · Decision date May 5, 2026

FDA DECISIONP230020/S006

What did the FDA approve?

FDA records P230020/S006 as a supplement to PMA P230020, with the supplement type “135 Review Track For 30-Day Notice”. The recorded decision is approval, dated May 5, 2026.

FDA approval order statement

approval for the addition of an alternate test method (Bacterial Endotoxin Testing Chromogenic) for endotoxin testing of the Implantable Pulse Generator (IPG) and IPG Accessory Kit components of the Altius System and a change in the test lab supplier for endotoxin testing from Integer Uruguay to Labcorp and Integer Plymouth.
Regulatory pathway
PMA supplement
Supplement type
135 Review Track For 30-Day Notice
Clinical specialty
Neurology
Decision date
May 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P230020/S006
Regulatory pathway
PMA supplement
Product code
SAZ
Decision code
APPR
Decision date
May 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb.

Product code
SAZ
FDA device class
3

For the original device and its historical approval scope, see PMA P230020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P230020 · Original PMA

    Altius Direct Electrical Nerve Stimulation System

  2. P230020/S006 received

    Application receipt date recorded by FDA.

  3. P230020/S005 · Related supplement

    Altius Direct Electrical Nerve Stimulation System

  4. P230020/S007 · Related supplement

    Altius Direct Electrical Nerve Stimulation System

  5. P230020/S006 · FDA decision

    135 Review Track For 30-Day Notice

  6. P230020/S011 · Related supplement

    Altius Direct Electrical Nerve Stimulation System

Timeline entries are records held by MedtechLedger for P230020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230020

Product / regulatory recordCompanyPathwayDecision dateSource
Neuros Medical, Inc.PMA approvalAug 26, 2024FDA
Neuros Medical, Inc.PMA supplementDec 3, 2025FDA
Neuros Medical, Inc.PMA supplementFeb 28, 2026FDA
Neuros Medical, Inc.PMA supplementOct 16, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Neuros Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records